Guillaume Delorme

Guillaume Delorme has extensive experience in the pharmaceutical industry, currently serving as the Country Medical Director for BeiGene in Switzerland since January 2022, where contributions include the establishment of the Swiss affiliate and support for the launch of pivotal oncology products. Prior experience as Country Medical Director at AbbVie involved leading a large team and facilitating multiple drug launches in hematology and immunology. Guillaume also held various roles at Roche, driving strategic communications in precision medicine, and has a strong foundation in medical science liaison positions at Celgene and Sanofi Genzyme, focusing on hematology and rare diseases. Academic credentials include a PhD in Immunology and management training from renowned institutions, underscoring a robust scientific and leadership background.